What is Neurocrine Biosciences's interest expense?

Neurocrine Biosciences (NBIX) reported interest expense of $1.1M in Q1 2024.

How has Neurocrine Biosciences's interest expense changed year-over-year?

Neurocrine Biosciences's interest expense decreased by 0.0% year-over-year, from $1.1M to $1.1M.

What is the long-term trend for Neurocrine Biosciences's interest expense?

Over 2 years (2021 to 2023), Neurocrine Biosciences's interest expense has grown at a -57.8% compound annual growth rate (CAGR), from $25.8M to $4.6M.

Neurocrine Biosciences NBIX Interest Expense

Discontinued — last reported Q1 '24

Interest Expense at other companies

IncyteINCY

$569K-13.8%

Royalty PharmaRPRX

$93.72M+43.6%

ViatrisVTRS

$120.1M+4.0%

Johnson & JohnsonJNJ

$272M+33.3%

BiogenBIIB

——

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

See full

Revenue$814.5M+42.3%

Gross profit$800.7M+42.1%

Operating income$193.4M+719%

Net income$197.9M+2,405%

EPS (diluted)$1.91+2,288%

Balance sheet

See full

Cash & equivalents$274.5M+35.8%

Total debt$463.5M-6.0%

Total equity$3.4B+34.4%

Total assets$4.9B+33.0%

Cash flow

See full

Operating cash flow$145.8M+125%

CapEx$9.1M-15.0%

Free cash flow$136.7M+153%

Valuation

See full

Market cap$15.92B+19.9%

Enterprise value$16.11B+18.5%

P/E23.8×-19.6×

P/S5.1×-0.4×

Profitability

See full

Gross margin98.2%-0.3pp

Operating margin25.4%+4.9pp

Net margin21.6%+8.9pp

Returns & leverage

See full

Return on equity22.5%+10.1pp

Debt / equity0.1×-0.1×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:InterestExpense.

The official record: Neurocrine Biosciences’s 10-Q, filed May 1, 2024, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's interest expense?: Neurocrine Biosciences (NBIX) reported interest expense of $1.1M in Q1 2024.
How has Neurocrine Biosciences's interest expense changed year-over-year?: Neurocrine Biosciences's interest expense decreased by 0.0% year-over-year, from $1.1M to $1.1M.
What is the long-term trend for Neurocrine Biosciences's interest expense?: Over 2 years (2021 to 2023), Neurocrine Biosciences's interest expense has grown at a -57.8% compound annual growth rate (CAGR), from $25.8M to $4.6M.